Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 July 2023 | Story André Damons | Photo Supplied
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), with his certificate after winning the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

A research paper by a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS) has won the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa.

The abstract, by Dr Osayande Evbuomwan, was about evaluating the efficacy of a new nuclear medicine radiopharmaceutical in the identification of active disease in patients with rheumatoid arthritis. It was selected for this award by a special committee at the recently concluded SNMMI 2023 Annual Meeting, which took place between 24 and 27 June in Chicago, USA.

Dr Evbuomwan received the award at the Annual Meeting on 26 June.

“It is a good feeling, and I am proud of the UFS Department of Nuclear Medicine for pulling this off. It is another example that hard work pays,” he says.

Comparing this radiopharmaceutical to ultrasound

Dr Evbuomwan says the research that generated the award-winning abstract was aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. The study concluded that this particular radiopharmaceutical (Tc – 99m glucosamine) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints), and is capable of offering prognostic information in patients with rheumatoid arthritis.

This is the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says. He is currently working on comparisons of this radiopharmaceutical to ultrasound and clinical evaluation in the identification of active disease in patients with rheumatoid arthritis. He says there is also ongoing collaboration with the Rheumatology Division of the Internal Medicine Department, which has played a huge role in making this project fruitful.

“This award is an opportunity to put the department and university on the map, with world stage recognition. We believe that as the Nuclear Medicine Department continues to grow in human resources and equipment, the research output will also increase.”

Dr Gerrit Engelbrecht, Clinical Head of the Department of Nuclear Medicine at the UFS, says the whole department is very proud of Dr Evbuomwan’s accomplishments. “What makes his award even more remarkable is that he outperformed candidates from much larger, highly funded institutions,” he says.

This department announced last year the successful treatment outcome of a patient with metastatic castrate-resistant prostate cancer (MCRPC) – an advanced stage of prostate cancer – by using Lutetium 177 PSMA (Lu-177 PSMA) therapy. This was initially a case of advanced stage prostate cancer, which had failed first-line chemotherapy, leaving little or no other treatment options.

News Archive

OSM Camerata first place winner in international competition
2017-09-08

Description: Camerata Tags: OSM Camerata, Ictus International Music Competition, Marius Coetzee, Odeion School of Music 

The OSM Camerata with conductors, Xavier Cloete and
Gerhard de Jager received first place in the
University/Conservatory Orchestra category.
Photo: Supplied



The OSM Camerata received first place in the 2017 Ictus International Music Competition for bands and orchestras. Marius Coetzee from the Odeion School of Music at the University of the Free State said: “The award was announced in time for the celebration of the orchestra’s fifth birthday.”

OSM a catalyst for excellence
The OSMC was strategically founded in 2012 by Coetzee as the OSM’s flagship chamber ensemble, with the main objective of creating a catalyst for excellence.

Over the past five years, the OSMC has premiered 15 new works by South African composers specially commissioned for them. Highlights remain its participation in the 13th International Conservatory Festival in St Petersburg Russia, where the ensemble received a standing ovation during a gala concert in the Glazunov Concert Hall, as well as the world première of the Cello Concerto for an African Cellist by South African composer, Hans Huyssen, with South African cellist, Heleen du Plessis as soloist. The CD was released in 2014 on the New Zealand Classical Music label, Ode Records in Auckland, New Zealand and was one of five CDs nominated for the Listeners' Choice Award New York in March 2014.

Competition draws participation from Washington to Bloemfontein

The inaugural year of this annual competition drew applicants from Washington State in the US all the way to Bloemfontein in the Free State. Video submissions were judged and narrowed down to a final round from which prize winners were selected.

The OSM Camerata with conductors, Xavier Cloete and Gerhard De Jager, received first place in the University/Conservatory Orchestra category. 

The competition was founded to highlight the work that music educators, conductors, students, performers and community members make in ensembles at the university, community, youth, high school and middle school levels. 

Competition director, Alex Serio says that “many people do not realise the amount of work that it takes to make these ensembles run. What is more is that most of the public does not realise the level of artistic excellence that can be achieved in these ensembles. Ictus International Music Competition was founded to highlight this level

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept